Steven Day's most recent trade in Adobe Inc was a trade of 1,429 Restricted Stock Units done . Disclosure was reported to the exchange on Sept. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 1,429 | 4,286 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 1,429 | 6,936 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.76 per share. | 15 Sep 2026 | 708 | 6,228 (0%) | 0% | 257.8 | 182,494 | Common Stock |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 312 | 936 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2026 | 312 | 5,661 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.76 per share. | 15 Sep 2026 | 154 | 5,507 (0%) | 0% | 257.8 | 39,695 | Common Stock |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2026 | 58 | 231 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2026 | 58 | 5,377 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 264.04 per share. | 15 Aug 2026 | 28 | 5,349 (0%) | 0% | 264.0 | 7,393 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2026 | 100,000 | 100,000 | - | - | Stock Option | |
| Adobe | Steven Day | Interim CFO and SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 22,616 | 22,616 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 419 | 5,862 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 419 | 5,526 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.56 per share. | 15 Jul 2026 | 207 | 5,319 (0%) | 0% | 224.6 | 46,484 | Common Stock |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 153 | 5,182 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 153 | 1,522 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.56 per share. | 15 Jul 2026 | 75 | 5,107 (0%) | 0% | 224.6 | 16,842 | Common Stock |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 63 | 5,060 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 63 | 375 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 55 | 5,024 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2026 | 55 | 109 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.55 per share. | 15 Jul 2026 | 31 | 5,029 (0%) | 0% | 224.5 | 6,961 | Common Stock |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.56 per share. | 15 Jul 2026 | 27 | 4,997 (0%) | 0% | 224.6 | 6,063 | Common Stock |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 312 | 1,248 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 312 | 5,048 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 234 | 0 | - | - | Restricted Stock Units | |
| Adobe | Steven Day | Interim CFO and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 234 | 4,852 (0%) | 0% | 0 | Common Stock | |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 206.36 per share. | 15 Jun 2026 | 154 | 4,894 (0%) | 0% | 206.4 | 31,779 | Common Stock |
| Adobe | Steven Day | Interim CFO and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 206.36 per share. | 15 Jun 2026 | 116 | 4,736 (0%) | 0% | 206.4 | 23,938 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 95,333 | 95,333 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2026 | 70,000 | 70,000 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 4.47 per share. | 18 Jun 2025 | 43,497 | 57,116 (0%) | 0% | 4.5 | 194,432 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 50,000 | 50,000 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 37,907 | 37,907 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 2.45 per share. | 05 Jan 2023 | 109,381 | 272,384 (0%) | 0% | 2.4 | 267,983 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 2.51 per share. | 02 Feb 2022 | 101,682 | 163,003 (0%) | 0% | 2.5 | 255,222 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 100,000 | 0 | - | - | Restricted Stock Units | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 100,000 | 100,000 (0%) | 0% | - | Common Stock | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.06 per share. | 04 Jan 2022 | 38,679 | 61,321 (0%) | 0% | 3.1 | 118,346 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |